文献速递主动脉疾病外周动脉疾病

合并髂动脉慢性完全闭塞的腹主动脉瘤腔内与杂交血运重建

Endovascular and Hybrid Revascularization for Concomitant Abdominal Aortic Aneurysm and Iliac Chronic Total Occlusion.
PubMed 文献 · Ann Vasc Surg · 2026-08-07

BACKGROUND: Endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysm (AAA) and iliac chronic total occlusion is technically challenging due to difficulties with device delivery, compromised seal zones, and increased risk of complications.…

要点

  • 合并髂动脉慢性完全闭塞的腹主动脉瘤患者行EVAR技术成功率高且远期耐久。
  • 个体化选择分叉型或主髂单侧型支架并联合辅助技术是关键。
  • 术后需终身 surveillance 以监测内漏和瘤囊变化。

核心结论

  • 对于合并髂动脉慢性完全闭塞的腹主动脉瘤,在仔细选择病例、定制器械选择和辅助技术支持下,EVAR可行且耐久。

主要发现

  • 11例患者中位年龄67岁,91%为男性,所有患者均为单侧髂动脉慢性完全闭塞,81.8%合并对侧髂动脉狭窄病变。
  • 4例(36%)采用分叉型EVAR,7例(64%)采用主髂单侧型(AUI)配置,其中6例联合股股交叉转流。
  • 辅助技术包括所有患者置入覆膜支架、9%使用选择性再入导管、9%使用血管内碎石术,45%经皮完成。
  • 中位随访86个月(IQR 66-115)时,91%症状持续缓解且移植物通畅,90%瘤囊回缩或稳定;1例在11.5年时因Ib型内漏出现晚期瘤囊扩张,经腔内成功治疗。

关键数值与推荐

  • 技术成功定义为成功部署预定支架配置(髂动脉再通后分叉型或主髂单侧型伴/不伴股股交叉转流),实现动脉瘤隔绝且目标血管通畅,无中转开放手术或术中死亡。

临床怎么用

  • 对于合并髂动脉慢性完全闭塞的腹主动脉瘤患者,可考虑EVAR治疗,但需仔细选择病例、个体化选择支架配置并联合辅助技术。
  • 术后需终身监测以及时发现内漏和瘤囊变化。

局限性

  • 回顾性单中心小样本病例系列,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysm (AAA) and iliac chronic total occlusion is technically challenging due to difficulties with device delivery, compromised seal zones, and increased risk of complications. Evidence on long-term outcomes in this subgroup remains limited. METHODS: A retrospective case series of all patients undergoing EVAR for infrarenal AAA with concomitant iliac artery chronic total occlusion at a tertiary vascular center between January 2009 and December 2024. Demographics, anatomical characteristics, procedural strategies, adjunctive techniques, and outcomes were analyzed. Technical success was defined as successful deployment of the intended endograft configuration-bifurcated following iliac recanalization or aorto-uni-iliac (AUI) with/without femoro-femoral crossover-achieving aneurysm exclusion with patent target vessels, without conversion to open repair or intraoperative death. RESULTS: Eleven patients (median age 67 years, 91% male) were treated. All patients had unilateral iliac chronic total occlusion; 81.8% had additional contralateral iliac stenotic disease. Four patients (36%) underwent bifurcated EVAR and seven (64%) received an AUI configuration, with femoro-femoral crossover in six. Adjunctive techniques included covered stent placement in all patients, selective re-entry catheter use (9%), and intravascular lithotripsy (9%). Nearly half (45%) were performed percutaneously. Technical success was achieved in all cases with no 30-day mortality. Perioperative complications occurred in two patients, both managed successfully. At median follow-up of 86 months (IQR 66-115), 91% had sustained symptom resolution, graft patency was preserved, and sac regression or stability occurred in 90%. One patient developed late sac expansion from a type Ib endoleak at 11.5 years, successfully treated endovascularly. CONCLUSION: EVAR for AAA with iliac chronic total occlusion is feasible and durable when guided by careful case selection, tailored device choice, and use of adjunctive techniques. Long-term outcomes in this series demonstrate high technical success, durability, and favorable AAA sac behavior, supporting its role in anatomically hostile aortoiliac disease. Lifelong surveillance remains essential.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hassan S, Dean A, Kusel K, et al. Endovascular and Hybrid Revascularization for Concomitant Abdominal Aortic Aneurysm and Iliac Chronic Total Occlusion. Ann Vasc Surg. 2026. PMID: 42567307. doi:10.1016/j.avsg.2026.07.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。